Search Results

You are looking at 81 - 90 of 542 items for :

  • "pathology" x
  • Refine by Access: Content accessible to Me x
Clear All
Full access

Nandan Maruti Shanbhag and Joycelyn Condace Phillip

Breast. Pathology: 80% are of Invasive Ductal Histology with about 9% Ductal Carcinoma Insitu. Stage: 55% are Advanced Breast Cancers. Hormone Status: More than 50% of the Tumours were Hormone Positive and Her2Neu Negative. Triple Negative Breast Cancer

Full access

Benjamin O. Anderson

limited-resource countries: early detection and access to care . Breast J 2006 ; 12 [ Suppl 1 ]: S16 – 26 . 11. Shyyan R Masood S Badwe RA . Breast cancer in limited-resource countries: diagnosis and pathology . Breast J 2006 ; 12 [ Suppl

Full access

Madhulika Urella, Jai Kumar Khatri, Anwar Khurram, Vivek Yadala, Adarsh Sidda, Noman Jang Khan, and Maria Tria Tirona

patients (56%) had squamous cell lung cancer and 19 patients (44%) had adenocarcinoma pathology, 35 patients (79.5%) received Durvalumab, 9 patients (20.4%) did not receive Durvalumab. Of the 9 patients, 3 patients were lost to follow up, 3 patients

Full access

Benigno Emmanuel Rodriguez Soto, Lorena López Zepeda, Alejandro Noguez Ramos, Daniela Vázquez Juarez, Daniela Shveid Gerson, Yazmin Carolina Blanco Vázquez, Samuel Rivera Rivera, Alberto Villalobos Prieto, Gabriela Olivia Regalado Porras, Ivonne Salcedo Sullk, Fernando Pérez Zincer, Christian Patricio Camacho Limas, Juan Alberto Serrano Olvera, Álvaro Aguayo González, Guillermo Manuel Olivares Beltrán, and Raquel Gerson Cwilich

. The median age was 52.2 years (22-79). Within the characteristics of the pathology, 34 patients had infiltrating ductal carcinoma, 8 infiltrating lobular and 2 mixed histology. Regarding the metastasis pattern, 29 presented visceral and 15 non

Full access

Barbara S Schwartzberg, A. M. Nisar Syed, and Craig Wengler

unplanned risk-adjusted post-IORT WBRT. Pt outcomes based on BMI and the unplanned need (positive lymph nodes, tumor size > 30 mm on final pathology) for post-IORT WBRT were analyzed in the IRB-approved single arm prospective multi-institution ExBRT trial

Full access

Saman S Karimi and Maria Gonzalez

nodes retrieved, and the status of the mesorectum. All specimens were grossed by trained pathology assistants following our grossing institutional guidelines. In all cases, the grosser revisited the specimen to retrieve additional lymph nodes if the

Full access

Qingqing Zhou, Chenchen Zhu, Zhen Shen, Jing Zhu, Tianjiao Zhang, Min Li, Jiwei Qin, Lili Qian, Chuan Chen, Hanyuan Liu, Zhihao Xu, Dabao Wu, Björn Nashan, and Ying Zhou

surgery. Patients with clear cell ovarian cancer had the highest incidence of VTE (26.32%) among all the pathology types. 81.82% of patients with VTE were at advanced stage (III and IV). After the primary cytoreduction surgery, 7.79% of patients developed

Full access

E. S. Delpassand, Rodolfo Nunez, D. Ranganathan, N. Wagh, A. Shafie, A. Gaber, I. Tworowska, and A. Abbasi

status of the subject, from all available Standard of Truth (SOT) pathology, clinical, and conventional imaging studies. A total of 63 subjects were considered for statistical analysis. Results: All the images were of high quality. Reader 1 had a

Full access

Sumesh Kachroo, Changxia Shao, Kaushal Desai, Jinghua He, Fan Jin, and Shuvayu Sen

the deidentified Flatiron Health-Foundation Medicine Clinico-Genomic Database linking clinical electronic health records and comprehensive genomic profiling (CGP) data from January 2011-September 2018. Patients ≥18 years with confirmed SCLC pathology

Full access

Kristen Kelley, Audrey York, Benjamin Haaland, Xuechen Wang, Shiven Patel, Adriana Coletta, and Christos Vaklavas

, pathology, and disease recurrences were collected. Stratification occurred by stage, age, receptor status, and treatment. Univariate and multivariate logistic models were used to investigate the relationship between endpoints and dosing time. Contingency